THE ECONOMIC BURDEN OF METASTATIC NON-SMALL CELL LUNG CANCER IN US PATIENTS WITHOUT AN EGFR OR ALK MUTATION

被引：0
|
作者：
Simmons, D. [1 ]
Welch, E. [2 ]
Pyrih, N. [3 ]
Jiang, Z. [1 ]
Xiao, Y. [1 ]
Jassim, R. [1 ]
机构：
[1] AstraZeneca, Gaithersburg, MD USA
[2] Panalgo, Boston, MA USA
[3] Cobbs Creek Healthcare, Concordville, MD USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE270
引用
收藏
页码：S108 / S108
页数：1
相关论文
共 50 条
  • [1] Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer
    Hu, Haoyue
    Tan, Songtao
    Xie, Meng
    Guo, Peng
    Yu, Qiang
    Xiao, Juan
    Zhao, Kangrui
    Liao, Qiong
    Wang, Yi
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [2] Concurrent EGFR Mutation and ALK Translocation in Non-Small Cell Lung Cancer
    Sweis, Randy F.
    Thomas, Sachdev
    Bank, Bruce
    Fishkin, Paul
    Mooney, Colin
    Salgia, Ravi
    CUREUS, 2016, 8 (02):
  • [3] Adverse Event Burden of Oral Tyrosine Kinase Inhibitors in EGFR and ALK Metastatic Non-Small Cell Lung Cancer
    Riley, D.
    Kaur, N.
    Baglione, A.
    Hall, R.
    Barnes, L.
    Gentzler, R.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1092 - S1092
  • [4] ECONOMIC BURDEN OF BRAIN METASTASES IN PATIENTS WITH ALK plus NON-SMALL CELL LUNG CANCER IN CHINA
    Xiao, F.
    Peng, X.
    Li, R.
    Luan, L.
    Le, H.
    Dong, P.
    VALUE IN HEALTH, 2024, 27 (12) : S99 - S99
  • [5] Impact of EGFR mutation and ALK rearrangement on the outcomes of non-small cell lung cancer patients with brain metastasis
    Balasubramanian, Suresh K.
    Sharma, Mayur
    Venur, Vyshak A.
    Schmitt, Philipp
    Kotecha, Rupesh
    Chao, Samuel T.
    Suh, John H.
    Angelov, Lilyana
    Mohammadi, Alireza M.
    Vogelbaum, Michael A.
    Barnett, Gene H.
    Jia, Xuefei
    Pennell, Nathan A.
    Ahluwalia, Manmeet S.
    NEURO-ONCOLOGY, 2020, 22 (02) : 267 - 277
  • [6] The Clinical and Economic Impact of Inaccurate EGFR Mutation Tests in the Treatment of Metastatic Non-Small Cell Lung Cancer
    Cheng, Mindy M.
    Palma, John F.
    Scudder, Sidney
    Poulios, Nick
    Liesenfeld, Oliver
    JOURNAL OF PERSONALIZED MEDICINE, 2017, 7 (03):
  • [7] EGFR mutation profile in Australian patients with non-small cell lung cancer
    Mead, Scott
    Lucas, Mark
    Pang, Jia-Min
    Fellowes, Andrew
    Harraway, James
    Svobodova, Suzanne
    Amanuel, Benhur
    Fox, Stephen
    PATHOLOGY, 2021, 53 (07) : 933 - 936
  • [8] EGFR Mutation Testing in Non-Small Cell Lung Cancer
    Sriram, Krishna B.
    Francis, Santiyagu M. Savarimuthu
    Tan, Maxine E.
    Bowman, Rayleen V.
    Yang, Ian A.
    Fong, Kwun M.
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2010, 6 (04) : 310 - 321
  • [9] Impact of EGFR and ALK mutation on the outcomes of non-small cell lung cancer (NSCLC) patients with brain metastases.
    Balasubramanian, Suresh Kumar
    Venur, Vyshak Alva
    Chao, Samuel T.
    Angelov, Lilyana
    Mohammadi, Alireza Mohammad
    Barnett, Gene H.
    Jia, Xuefei
    Ahluwalia, Manmeet Singh
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] Investigation of EGFR and ALK mutation frequency and treatment results in advanced non-small cell lung cancer
    Komurcuoglu, Berna
    Karakurt, Gamze
    Kaya, Ozge O.
    Diniz, Gulden
    Kirbiyik, Ozgur
    Evkan, Aysen
    Yalniz, Enver
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (SUPPL 1) : S183 - S190
12345